Prospective Evaluation of Bleeding Risk of Anticoagulant and Anti-platelet Therapy
NCT ID: NCT00625248
Last Updated: 2013-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12000 participants
OBSERVATIONAL
2008-02-29
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications
NCT00603148
Does Thinning the Blood During Surgery Prevent Blood Clots Following Total Knee Replacement Surgery
NCT00253851
Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2
NCT02526485
Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery
NCT03212365
Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty
NCT01809054
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. To evaluate differences in outcomes in patients not receiving any anticoagulant or antiplatelet therapy compared to patients receiving various types of drugs with anticoagulant or antiplatelet therapeutic effects.
3. To evaluate and compare the adverse event profiling all patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
no anthithrombotic
procedures where there were no antithrombotics
Antithrombotics
With or without or discontinuted use of Antithrombotics
Antithrombotic - continued
patients who are on antithrombotics
Antithrombotics
With or without or discontinuted use of Antithrombotics
Discontinued Antithrombotic
Patients who were on antithrombotics but have been discontinued
Antithrombotics
With or without or discontinuted use of Antithrombotics
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antithrombotics
With or without or discontinuted use of Antithrombotics
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pain Management Center of Paducah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Laxmaiah Manchikanti, MD
Medical Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laxmaiah Manchikanti, MD
Role: PRINCIPAL_INVESTIGATOR
Ambulatory Surgery Center, Paducah
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pain Management Center of Paducah
Paducah, Kentucky, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Manchikanti L, Malla Y, Wargo BW, Cash KA, McManus CD, Damron KS, Jackson SD, Pampati V, Fellows B. A prospective evaluation of bleeding risk of interventional techniques in chronic pain. Pain Physician. 2011 Jul-Aug;14(4):317-29.
Manchikanti L, Malla Y, Wargo BW, Fellows B. Infection control practices (safe injection and medication vial utilization) for interventional techniques: are they based on relative risk management or evidence? Pain Physician. 2011 Sep-Oct;14(5):425-34.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
protocol 18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.